Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Active Ingredients
01 NESIRITIDE RECOMBINANT (1)
Applicant
01 SCIOS LLC (1)
Dosage Form
01 FOR SOLUTION;INTRAVENOUS (1)
Dosage
01 1.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
Country
01 USA (1)